ViroCell Biologics Retroviral & Lentiviral Vector CDMO
Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing
Notes from the Inside Viral Vector Science Videos + Webinars Articles
In the News Press Releases Conferences
Careers
Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Notes from the Inside Viral Vector Science Videos + Webinars Articles
ViroCell Biologics Retroviral & Lentiviral Vector CDMO
News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us

Advanced Therapies Week, Jan 16-19, 2024, Miami

Contact us if you're going to #Miami! Farzin Farzaneh, PhD, Traci Kyes and I will be there. Thank you #Phacilitate #ATW24

John W. Hadden II

ViroCell Biologics #viralvectors #CDMO #celltherapy #genetherapy #GMPmanufacturing #biotech #cellandgenetherapy

Florence BuchananJanuary 13, 2024
LinkedIn0 0 Likes
Previous

Panel Discussion: Comparing Viral vs Non-Viral Engineering Methods, CAR-TCR Europe, Feb 28, 2024, London

Florence BuchananFebruary 20, 2024
Next

J.P. Morgan Healthcare Conference, Jan 8-11, 2024, San Francisco

Florence BuchananJanuary 10, 2024
 

Webinar

Next-gen vectors: advancing in vivo and ex vivo gene delivery through intelligent design
Sept 3, 2025

videos
 

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

Get in touch
videosNewsroomCareersContact UsTerms of UsePrivacy Notice

London

 

ViroCell Holdings Limited (trading as ViroCell Biologics), registered in England and Wales, Company No. 16812976. Registered Office: 5 New Street Square, London EC4A 3TW ©2026 ViroCell Holdings Limited. All rights reserved.